Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Inc. Regulatory News (DIG)

Share Price Information for Dunedin Inc. (DIG)

Share Price is delayed by 15 minutes
Get Live Data
302.00    0.00 (0.00%)
Bid:
302.00
Ask:
305.00
Spread: 3.00 (0.993%)
Market Cap: £356.03m
DIG Live PriceLast checked at - London Stock Exchange

Intraday Dunedin Inc. Share Chart

Board Changes

31 Jan 2025 10:43

RNS Number : 4807V
Dunedin Income Growth Inv Tst PLC
31 January 2025
 

Dunedin Income Growth Investment Trust PLC

Legal Entity Identifier (LEI): 549300PPXLZPR5JTL763

 

 

 

31 January 2025

 

 

Board Changes

The Board of Dunedin Income Growth Investment Trust PLC (the "Company") is pleased to announce the appointment of Arun Kumar Sarwal as an independent non-executive Director of the Company with effect from 1 February 2025. 

 

Arun Kumar Sarwal is a Chartered Accountant and has broad experience of global equities and fund management over some 35 years in the UK, Europe, and Asia. He is a Board Advisor to Tumelo and a director and Chairman of the Audit Committee of JPMorgan European Discovery Trust plc. His previous roles include CEO of Broadridge Fund Communication Solutions, Senior Vice President of SS&C Technologies, COO and CFO at Scottish Widows Investment Partnership and global roles at ABN AMRO and Societe Generale Investment Bank.

 

Arun will stand for election at the Annual General Meeting to be held in May 2025. There are no other disclosures required under Section 6.4.8 of the FCA's Listing Rules in relation to this appointment.

 

As previously stated, Jasper Judd and David Barron, who both joined the Board in February 2016 will retire as Directors at the conclusion of the Company's Annual General Meeting in May. It is the Board's intention that Arun Kumar Sarwal will be appointed as Chairman of the Audit Committee in place of Jasper Judd at that time. As previously stated, Howard Williams, who has been a Director since April 2018, will succeed David Barron as Chair of the Company following the AGM.

 

It is the Board's intention to recruit a further Director in 2025 to bring the number of Directors back to five.

 

 

 

For further information, please contact:

 

G Hay Smith

abrdn Holdings Limited

Company Secretary

0131 372 9370

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPKDBQKBKDBDN
Date   Source Headline
30th Sep 20245:12 pmRNSTransaction in Own Shares
30th Sep 202412:41 pmRNSGearing disclosure
30th Sep 202412:20 pmRNSNet Asset Value(s)
27th Sep 20245:20 pmRNSTransaction in Own Shares
27th Sep 202412:29 pmRNSNet Asset Value(s)
26th Sep 20245:22 pmRNSTransaction in Own Shares
26th Sep 202412:01 pmRNSNet Asset Value(s)
25th Sep 20245:14 pmRNSTransaction in Own Shares
25th Sep 202412:38 pmRNSNet Asset Value(s)
24th Sep 202412:46 pmRNSNet Asset Value(s)
23rd Sep 20245:17 pmRNSTransaction in Own Shares
23rd Sep 20244:05 pmRNSGearing disclosure
23rd Sep 202412:43 pmRNSNet Asset Value(s)
20th Sep 20245:18 pmRNSTransaction in Own Shares
20th Sep 202412:56 pmRNSDirector/PDMR Shareholding
20th Sep 202412:25 pmRNSNet Asset Value(s)
19th Sep 20245:43 pmRNSTransaction in Own Shares
19th Sep 202411:30 amRNSNet Asset Value(s)
18th Sep 20245:20 pmRNSTransaction in Own Shares
18th Sep 202412:18 pmRNSNet Asset Value(s)
17th Sep 20245:24 pmRNSTransaction in Own Shares
17th Sep 20241:01 pmRNSNet Asset Value(s)
16th Sep 20245:24 pmRNSTransaction in Own Shares
16th Sep 20241:40 pmRNSGearing disclosure
16th Sep 202412:27 pmRNSNet Asset Value(s)
13th Sep 20245:16 pmRNSTransaction in Own Shares
13th Sep 20241:12 pmRNSNet Asset Value(s)
12th Sep 20245:12 pmRNSTransaction in Own Shares
12th Sep 20243:53 pmRNSPortfolio disclosure
12th Sep 202412:15 pmRNSNet Asset Value(s)
11th Sep 20245:13 pmRNSTransaction in Own Shares
11th Sep 20241:07 pmRNSNet Asset Value(s)
10th Sep 20245:12 pmRNSTransaction in Own Shares
10th Sep 202411:47 amRNSNet Asset Value(s)
9th Sep 20245:23 pmRNSTransaction in Own Shares
9th Sep 20241:50 pmRNSGearing disclosure
9th Sep 20241:06 pmRNSNet Asset Value(s)
6th Sep 20245:12 pmRNSTransaction in Own Shares
6th Sep 202412:27 pmRNSNet Asset Value(s)
5th Sep 20245:10 pmRNSTransaction in Own Shares
5th Sep 202412:28 pmRNSNet Asset Value(s)
5th Sep 202411:02 amRNSMonth End Net Asset Value(s)
4th Sep 20245:03 pmRNSTransaction in Own Shares
4th Sep 202412:07 pmRNSNet Asset Value(s)
3rd Sep 20245:07 pmRNSTransaction in Own Shares
3rd Sep 20241:30 pmRNSNet Asset Value(s)
2nd Sep 20245:27 pmRNSTransaction in Own Shares
2nd Sep 20242:58 pmRNSGearing disclosure
2nd Sep 20249:37 amRNSTotal Voting Rights
30th Aug 20245:15 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.